1. Committee on Developing Biomarker-Based Tools for Cancer Screening, Diagnosis, and Treatment. Nass SJ, Moses HL (eds). Cancer Biomarkers: The Promises and Challenges of Improving Detection and Treatment. National Academies Press: Washington, DC, 2007.
2. Haddow J, Palomaki G . ACCE: a model process for evaluating data on emerging genetic tests. In: Khoury M, Little J, Burke W (eds). Human Genome Epidemiology: A Scientific Foundation for Using Genetic Information to Improve Health and Prevent Disease. Oxford University Press: New York, 2003:217–233.
3. Teutsch SM, Bradley LA, Palomaki GE, et al.; EGAPP Working Group. The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative: methods of the EGAPP Working Group. Genet Med 2009;11:3–14.
4. Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. Recommendations from the EGAPP Working Group: can tumor gene expression profiling improve outcomes in patients with breast cancer? Genet Med 2009;11:66–73.
5. Baggerly KA, Coombes KR . What information should be required to support clinical “omics” publications? Clin Chem 2011;57:688–690.